F HOFFMANN LA ROCHE AG TRADE DATA ANALYSIS
Access comprehensive trade data for F Hoffmann La Roche Ag with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
F Hoffmann La Roche Ag – Overview
Eximpedia analyzes F Hoffmann La Roche Ag export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of F Hoffmann La Roche Ag that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
F Hoffmann La Roche Ag Buyers, Suppliers & Shipments
F Hoffmann La Roche Ag import markets
Explore the F Hoffmann La Roche Ag import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3002150000 | 27.23 | 24 | 48.00 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3004900000 | 12.47 | 18 | 36.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004500000 | 7.55 | 2 | 4.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004390000 | 0.36 | 6 | 12.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| GERMANY | 25.31 | 23 | 46.00 |
| SWITZERLAND | 11.78 | 10 | 20.00 |
| UNITED STATES | 5.28 | 5 | 10.00 |
| JAPAN | 3.69 | 7 | 14.00 |
| FRANCE | 0.64 | 1 | 2.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 47.61 | 50 | 100.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LLC | 253.12 | 526 |
| JSC R FARM | 346.89 | 560 |
| CJSC ROCH MOSCOW | 381.03 | 196 |
| LLC NAUKA MEDICINE VETERINARY | 43464.58 | 134 |
| TOV ALSI LTDKYIV | 248396.75 | 5287 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| CELLSYSTEMS GMBH | 3116.18 | 2 |
| MY BIOTECH SRO | 40348.40 | 20 |
| WALTER FRIES TRADE AND TRANSPORT | 100422.83 | 1803 |
| TH GEYER GMBH AND CO KG | 117078.48 | 3096 |
If you are looking to establish relationship with F Hoffmann La Roche Ag Automation you can save time by getting access to the key decision makers and get a detailed report.
F Hoffmann La Roche Ag Import Shipments
Discover the F Hoffmann La Roche Ag with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004500000 | 1. MEDICINAL PRODUCTS FOR HUMANS, CONTAINING VITAMINS, PACKAGED FOR RETAIL TRADE: - ROACCUTAN(R), CAPSULES OF 10 MG, 10 CAPSULES IN A BLISTER; 3 BLISTERS IN A BOX (ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS: 10 MG OF ISOTRETINOIN (SYNTHETIC DRUG, WHICH BY ITS STRUCTURE IS A STRUCTURAL ANALOGUE OF VITAMIN A, THE CONTENT OF WHICH EXCEEDS THREE TIMES THE RECOMMENDED AVERAGE DAILY INTAKE (RDA)) - ARTICLE: 10198671 SERIES: B9240-1B01- 61422PACK - ROACCUTAN(R), CAPSULES OF 20 MG, 10 CAPSULES IN A BLISTER; 3 BLISTERS IN A BOX (ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS: 20 MG OF ISOTRETINOIN (A SYNTHETIC DRUG, WHICH BY ITS STRUCTURE IS A STRUCTURAL ANALOGUE OF VITAMIN A, THE CONTENT OF WHICH IS MORE THAN THREE TIMES EXCEEDS THE RECOMMENDED AVERAGE DAILY INTAKE (RDA)) - ARTICLE: 10198627 SERIES: B9841B03 - 3915 UNITS - ARTICLE: 10198627 SERIES: B9842B01 - 31826 UNITS - ARTICLE: 10198627 SERIES: B9843B01 - 2478 UNITS - ARTICLE: 10198627 SERIES: B9844B02 - 17616UP PRODUCER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY AND SECONDARY PACKAGING |  |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - MADOPAR(R), TABLETS, 200 MG/50 MG, 100 TABLETS IN A BOTTLE; 1 BOTTLE IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: LEVODOPA 200 MG, TABENSERAZIDE 50 MG IN THE FORM OF BENSERAZIDE HYDROCHLORIDE 57 MG) - ARTICLE: 10199713 SERIES: M4555M4 -3133 UNITS - ARTICLE: 10199713 SERIES: M4799M1 -1080 UNITS MANUFACTURER: PRODUCTION NO PACKAGED PRODUCTS, PRIMARY AND SECONDARY PACKAGING, CONTROL TESTS QUALITY: DELPHARM MILANO, S.R.L., ITALY; ISSUE OF THE SERIES: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: ITTRADEMARK: ROCHE, MADOPAR | |
|
ITALY | UKRAINE | 0 |
| 3004500000 | 1. MEDICINAL PRODUCTS FOR HUMANS, CONTAINING VITAMINS, PACKAGED FOR RETAIL TRADE: - ROACCUTAN(R), CAPSULES OF 20 MG, 10 CAPSULES IN A BLISTER; 3 BLISTERS IN A BOX (ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS: 20 MG OF ISOTRETINOIN (A SYNTHETIC DRUG, WHICH BY ITS STRUCTURE IS A STRUCTURAL ANALOGUE OF VITAMIN A, THE CONTENT OF WHICH EXCEEDS THREE TIMES THE RECOMMENDED AVERAGE DAILY INTAKE (RDA)) - ARTICLE: 10198627 SERIES: B9826B03 - 16194UP - ARTICLE :10198627 SERIES:B9829B02- 14538PACK- ARTICLE:10198627 SERIES:B9830B01- 4416PACK- ARTICLE:10198627 SERIES:B9830B02- 15194PACK- ARTICLE:10198627 SERIES:B9841B02- 14603PACK- ARTICLE:1019 8627 SERIES: B9843B02- 27195 UNITS - ARTICLE: 10198627 SERIES: B9844B01 - 10780UP ARTICLE: 10198627 SERIES: B9844B03- 2823-ARTICLE: 10198627 SERIES: B9846B01- 11230 PUPPIES: PRODUCTION OF NON-FASTED PRODUCTS, PRIMARY AND SECONDARY PACKAGING: N-LA ROSH LTD , SWITZERLAND COUNTRY OF MANUFACTURE: DECOMMERCIAL | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. HUMAN MEDICINES PACKAGED FOR RETAIL TRADE:-COTELLIC(R), FILM-COATED TABLETS, 20MG PER 21 TABLETS BLISTER; 3 BLISTERS IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 TABLET CONTAINS: COBIMETINIB 20MG IN FORMICOBIMETINIB HEMIFUMARATE 22.20MG) - ITEM: 10213155 SERIES: B5010M8 -20UP MANUFACTURER: QUALITY CONTROL TESTING ON RELEASE (MICROBIOLOGICAL PURITY); BATCH RELEASE: F. HOFFMANN-LA ROCHE, SWITZERLAND; PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL TESTING FOR STABILITY: DELPHARM MILANO, S.R.L., ITALY; PRODUCTION OF UNPACKAGED PRODUCTS, QUALITY CONTROL TESTING FOR STABILITY AND RELEASE (EXCEPT MICROBIOLOGICAL PERSONAL PURITY) EXELLA GMBH END CO.KG, GERMANY. COUNTRY OF PRODUCTION: TRADEMARK: ROCHE" | |
|
GERMANY | UKRAINE | 0 |
| 3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGY, PACKAGED FOR RETAIL SALE: - KADSILA(R), POWDER FOR SOLUTION FOR INFUSION, 1 VIAL OF POWDER IN A CARTON BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS: UMABUEMTANSINE 160MG FOR THE PREPARATION OF 8ML CONCENTRATE FOR INFUSION CONTAINING TRASTUSUMAB EMTANSINE 20MG/ML)-ARTICLE:10158360 SERIES:B2819B27-68UPMANUFACTURER: ""MANUFACTURE OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING; SECONDARY PACKAGING; QUALITY CONTROL TESTING; ISSUE OF THE SERIES: F. HOFFMANN-LA ROCHE LTD"" "", SWITZERLAND MANUFACTURED BY: CH TRADE BRAND: ROCHE, KADSILA-KADSILA(R), POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1 VIAL WITH POWDER IN A CARDBOARD BOX (ACTIVE INGREDIENTS : 1 VIAL CONTAINS : TRASTUSUMABUEMTANSIN 100MG FOR THE PREPARATION OF 5ML CONCENTRATE FOR INFUSION CONTAINING TRASTUSUMABUEMTANSIN 20MG/ML)-ARTICLE: 10158357 SERIES: B3608B09 -133 MANUFACTURER: ""MANUFACTURER OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING; SECONDARY PACKAGING; QUALITY CONTROL TESTING; ISSUE OF THE SERIES: F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND COUNTRY OF MANUFACTURE: CHTRADE BRAND: ROCHE, KADSILA""" | |
|
SWITZERLAND | UKRAINE | 0 |
| 3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - ACTEMRA(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 20MG/ML IN 200MG/10ML VIAL; 1 VIAL IN A CARTON (ACTIVE INGREDIENTS: 1ML CONCENTRATE CONTAINS: 20MG TOCILIZUMAB; 1 VIAL CONTAINS: 200MG/10ML TOCILIZUMAB)-ARTICLE: 10231557 SERIES: B5020B32 -12UP-ARTICLE: 10231557 SERIES I: B5020B35 -113UMANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING: CHUGAY PHARMACEUTICAL MANUFACTURING CO. LTD, JAPAN; SECONDARY PACKAGING, SERIES ISSUED: F. HOFFMANN-LIAROSH LTD, SWITZERLAND. COUNTRY OF MANUFACTURE: JP TRADEMARK: ROCHE, ACTEMRA" | |
|
JAPAN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINE FOR HUMANS, PACKAGED FOR RETAIL TRADE:-OCREVUS(R), CONCENTRATE FOR SOLUTION FOR INFUSION OF 300MG/10ML IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 VIAL (10ML CONC COST FOR SOLUTION FOR INFUSION) CONTAINS : 300MG OKRELIZUMAB)- ITEM: 10228524 SERIES: H0079B32 -138UPMANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: ROSH DIAGNOSTICS GMBH, GERMANY; SECONDARY PACKAGING, SERIES ISSUED: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND COUNTRY OF PRODUCTION: DE TRADEMARK: ROCHE, OKREVUS" | |
|
GERMANY | UKRAINE | 0 |
| 3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: -AVASTIN(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/4ML IN 16ML (400MG) VIAL; 1 VIAL IN A CARTON (ACTIVE INGREDIENTS: 1 VIAL (4ML CONCENTRATE FOR INFUSION) CONTAINS: 100MG (25MG/ML) BEVACISUMAB; 1 VIAL (16ML CONCENTRATE FOR INFUSION) CONTAINS: 400MG (25MG/ML) BE VACIZUMABU)-ARTICLE: 10194470 SERIES: H0313B20 -1303UP MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL EXAMINATION, BATCH RELEASE: ROSH DIAGNOSTICS GMBH, GERMANY; QUALITY CONTROL TESTING: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, AVASTYN" | |
|
GERMANY | UKRAINE | 0 |
| 3004390000 | 1. MEDICINES FOR HUMANS CONTAINING HORMONES PACKAGED FOR RETAIL SALE:-RECORMON(R), SOLUTION FOR INJECTION OF 2000 IU/0.3ML IN 3 PRE-FILLED SYRINGES OF 2000 IU/0.3ML WITH 3 NEEDLES FOR INJECTIONS 27 G1/2 (NEEDLE PLACED IN PLASTIC PACKAGING) IN CONTOUR BLISTER PACKAGING CONSISTING OF 3 SEPARATE PLASTIC CONTAINERS (1 PRE-FILLED SYRINGE AND 1 NEEDLE IN ONE PLASTIC CONTAINER); 2 CIRCULAR PACKS (6 PRE-FILLED SYRINGES AND 6 NEEDLES) IN A CARTON (ACTIVE INGREDIENTS: 1 PRE-FILLED SYRINGE (0.3ML SOLUTION) CONTAINS: EPOETIN BETA 2000 IU (16.6 MCG) - ITEM: 10 247118 SERIES:H1065H05 -1723UPMANUFACTURER : PRODUCTION OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL TESTING, BATCH RELEASE: ROCHE DIAGNOSTICS GMBH, GERMANY. COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, REKORMON" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR HUMANS, PACKAGED FOR RETAIL TRADE: - EURISDI, POWDER FOR ORAL SOLUTION, 0.75MG/ML; POWDER FOR ORAL SOLUTION BOTTLE; 1 BOTTLE COMPLETE WITH 1 BOTTLE ADAPTER, 2 MULTI-USE ORAL SYRINGES OF 6ML (EACH IN A POLYTHELINE BAG) AND 2 ORAL SYRINGES FOR MULTI-USE USE OF 12ML (EACH IN A POLYETHYLENE PACKAGE), WHICH ARE INCLUDED IN A POLYETHYLENE PACKAGE; 1 BOTTLE AND 1 KIT CONTAINED IN A CARTON (ACTIVE INGREDIENTS: 1 BOTTLE CONTAINS: 60MG OF RISDYPLAM; 1ML OF RENEWED SOLUTION CONTAINS: 0.75MG OF RISDYPLAM)-ARTICLE:10232160 SERIES:B1051B04 -202UP-ARTICLE:1 0232160 SERIES: B1053B01 -112UP MANUFACTURER: QUALITY CONTROL TESTING ON RELEASE AND STABILITY, SECONDARY PACKAGING AND LABELING, BATCH RELEASE; PRODUCTION OF UNPACKED PRODUCT, PRIMARY PACKAGING (BOTTLE FILLING STAGE) AND LABELING, QUALITY CONTROL TESTING, MICROBIOLOGICAL PURITY TESTING: F. HOFFMANN-LA ROSH LTD, SWITZERLAND. COUNTRY OF PRODUCTION: CHTORGOV ELNA BRAND: ROCHE" | |
|
SWITZERLAND | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - HERCEPTIN(R), 440 MG LYOPHILISATE FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 440 MG LYOPHILISATE FOR CONCENTRATE FOR SOLUTION FOR INFUSION IN A VIAL, TOGETHER WITH 20 ML OF SOLVENT (SOLVENT: BACTERIOSTATIC WATER FOR INJECTIONS 20 ML , CONTAINING 1.1% BENZYL ALCOHOL AND WATER FOR INJECTIONS) IN A VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 MULTI-DOSE VIAL WITH LYOPHILISATE CONTAINS: TRASTUZUMAB 440 MG) - ARTICLE: 10200444 SERIES: N7731B12 - 128 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS: GENENTEK INC. ., USA; SECONDARY PACKAGING, QUALITY CONTROL TESTING, SERIES RELEASE, SOLVENT: F.HOFFMANN-LAROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: USTRADEMARK: ROCHE, HERCEPTIN | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. PHARMACEUTICAL PRODUCTS - EMICIZUMAB 60 MG, 105 MG, 150 MG, 30 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT; ""MEDICINES FOR THE PROVISION OF ADULTS, PATIENTS WITH HEMOPHILIA TYPES A OR B OR WILLEBRAND'S DISEASE"" ACCORDING TO THE BUDGET PROGRAM OF THE CPVK 2301400 ""PROVISION OF MEDICAL MEASURES OF INDIVIDUAL STATE PROGRAMS AND COMPLEX PROGRAMS OF A PROGRAMMATIC NATURE"". MEDICINAL MEANS FOR PEOPLE, THERAPEUTIC, PACKAGED FOR RETAIL TRADE: , SOLUTION FOR INJECTIONS OF 150 MG/1 ML OF 0.4 ML (60 MG) IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 60 MG/0.4 MLEMICIZUMAB) - ARTICLE: 10220435 SERIES: B0169B03 -327 UNITS (CALCULATED PER UNIT MEASUREMENT OF MG -19620 MG) - GEMLIBRA, SOLUTION FOR INJECTIONS OF 150 MG/ 1 ML OF 0.7 ML (105 MG) IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 105 MG/0.7 MLEMICIZUMAB) - ARTICLE: 10220529 SERIES: B0168B04 - 160 UNITS (CALCULATED PER UNIT MEASUREMENT OF MG - 16800 MG) - GEMLIBRA, SOLUTION FOR INJECTIONS OF 150 MG/ 1 ML BY 1 ML (150 MG) IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 150 MG/1 ML OF LEMICIZUMAB) - ARTICLE: 10220600 SERIES: B0167B12 - 35 UNITS (CALCULATED PER UNIT MEASUREMENT MG - 5250 MG) - GEMLIBRA, SOLUTION FOR INJECTIONS OF 30 MG/1 ML 1 ML (30 MG) IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 30 MG/1 ML OF EMICIZUMAB) - ARTICLE: 10220477 SERIES: B0170B01 - 14 UNITS (IN UNITS OF MG - 420 MG) MANUFACTURER: QUALITY CONTROL TEST, SECONDARY PACKAGING, SERIES RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: CHUGAI PHARMA MANUFACTURING CO., LTD., JAPAN. COUNTRY OF MANUFACTURE: JPTRADEMARK: ROCHE""" | |
|
JAPAN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - GEMLIBRA, SOLUTION FOR INJECTIONS OF 150 MG/1 ML OF 0.4 ML (60 MG) IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 60 MG/0.4 ML OF LEMICIZUMAB) - ARTICLE: 10220435 SERIES: B0169B03 - 1 PACK - GEMLIBRA, SOLUTION FOR INJECTION 150 MG/1 ML OF 0.7 ML (105 MG) IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 105 MG/0.7 ML OF EMICIZUMAB) - ARTICLE: 10220529 SERIES: B0168B04 - 1 PACK - GEMLIBRA, SOLUTION FOR INJECTIONS OF 150 MG/1 ML, 1 ML (150 MG) IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 150 MG/1 ML OF LEMICIZUMAB) - ARTICLE: 10220600 SERIES: B0167B12 - 1 PACK - GEMLIBRA, SOLUTION FOR INJECTIONS OF 30 MG/1 ML, 1 ML (30 MG) IN A VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 30MG/1ML OF EMICIZUMAB) - ARTICLE: 10220477 SERIES: B0170B01 - 1PC MANUFACTURER: QUALITY CONTROL TEST, SECONDARY PACKAGING, SERIES RELEASE: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: CHUGAI PHARMA MANUFACTURING CO., LTD., JAPAN. COUNTRY OF MANUFACTURE: JPTRADEMARK: ROCHE""" | |
|
JAPAN | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL TRADE: - PULMOZIM(R), SOLUTION FOR INHALATION, 2.5 MG/2.5 ML, 2.5 ML IN AN AMPOULE; 6 AMPOULES IN A CONTAINER; 1 CONTAINER IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 AMPOULE (2.5 ML) OF SOLUTION FOR INHALATION CONTAINS: DORNASE ALFA 1 2.5 MG 1), 1 MG OF DORNASE ALFA CORRESPONDS TO 1000 UNITS) - ARTICLE: 10243308 SERIES: N0021B35 - 160 UNITS MANUFACTURER: PRIMARY PACKAGING, VIAL UNDEVELOPED PRODUCTS: WOODSTOCK STERILE SOLUTIONS INC., USA, SECONDARY PACKAGING, SERIES RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND, QUALITY CONTROL TESTING: ROCHE DIAGNOSTICS GMBH, GERMANY COUNTRY OF MANUFACTURE: USTRADEMARK: ROCHE, PULMOZIM""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - FESGO(R), SOLUTION FOR INJECTIONS, 1200 MG/600 MG PER 15 ML SOLUTION FOR INJECTIONS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: PERTUZUMAB 1200 MG, TATRASTUZUMAB 600 MG IN 15 ML) - ARTICLE: 10228797 SERIES: B1303B09 - 15 UNITS - ARTICLE: 10228797 SERIES: B1303B18 - 16 UNITS - FESGO(R), SOLUTION FOR INJECTION, 600 MG/600 MG PER 10 ML SOLUTION FOR INJECTION IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: PERTUZUMAB 600 MG, TATRASTUZUMAB 600 MG IN 10 ML) - ARTICLE: 10228878 SERIES: B1309B11 - 165 UNITS MANUFACTURER: """"F. HOFFMANN-LA ROCHE LTD., SWITZERLAND. COUNTRY OF MANUFACTURE: CHTRADE MARK: ROCHE""" | |
|
SWITZERLAND | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - GAZIVA(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 1000 MG/40 ML OF 40 ML IN A BOTTLE; 1 BOTTLE IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 BOTTLE CONTAINS: 1000 MG OF OBINUTUZUMAB, WHICH CORRESPONDS TO THE CONCENTRATION BEFORE DILUTION OF 25 MG/ML) - ARTICLE: 10152192 SERIES: H0240B32 -178 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: ROSH DIAGNOSTICS GMBH, GERMANY; SECONDARY PACKAGING, SERIAL RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: DETRADE MARK: ROCHE, GAZIVA""" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - ZELBORAF(R), FILM-COATED TABLETS, 240 MG EACH, 8 TABLETS IN A BLISTER; 7 BLISTERS IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: VEMURAFENIB 240 MG IN THE FORM OF A CO-PRECIPITATE OF VEMURAFENIB AND HYPROMELLOSE ACETATE SUCCINATE (RATIO 3:7) - ARTICLE: 10206036 SERIES: M1384MJ - 120 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, SECONDARY PACKAGING , QUALITY CONTROL TESTS : DELPHARM MILANO S.R.L., ITALY; PRODUCTION SERIES: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: ITTRADEMARK: ROCHE, ZELBORAF""" | |
|
ITALY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - KOTELLIC, FILM-COATED TABLETS, 20 MG EACH, 21 TABLETS IN A BLISTER; 3 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: COBIMETINIB 20 MG IN THE FORM OF COBIMETINIB HEMIFUMARATE 22.20 MG) - ARTICLE: 10213155 SERIES: B5009M3 -21 UNITS MANUFACTURER: QUALITY CONTROL TEST AT RELEASE (MICROBIOLOGICAL PURITY); SERIES RELEASE: F. HOFFMANN-LA ROCHE, SWITZERLAND; PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL TESTS FOR STABILITY: DELFARM MILANO, S.R.L., ITALY; PRODUCTION OF BULK PRODUCTS, QUALITY CONTROL TESTS FOR STABILITY AND RELEASE (EXCEPT FOR MICROBIOLOGICAL PURITY) EXCELLA GMBH & CO.KG, GERMANY. COUNTRY OF MANUFACTURE: DETRADEMARK: ROCHE""" | |
|
GERMANY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - TAMIFLU(R), CAPSULES OF 75 MG, 10 CAPSULES IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS: OSELTAMIVIR 75.00 MG IN THE FORM OF OSELTAMIVIR PHOSPHATE 98.50 MG) - ARTICLE: 10177339 SERIES: F0241B10-25200UP MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS: SENEXI SAS, FRANCE; PACKAGING, QUALITY CONTROL TESTING, RELEASE SERIES: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND. COUNTRY OF MANUFACTURE: FRTRADE MARK: ROCHE, TAMIFLU""" | |
|
FRANCE | UKRAINE | 0 |
| 3002150000 | 1. PHARMACEUTICAL PRODUCTS - DORNAZAALFA 2.5MG/2.5ML IN AMPOULES, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""PURCHASE OF MEDICINES FOR CITIZENS SUFFERING FROM CYSTIC FIBROSIS"", ACCORDING TO THE BUDGET PROGRAM: KPKVK 2301400 ""PROVISION OF MEDICAL MEASURES OF INDIVIDUAL STATE PROGRAMS AND COMPLEX MEASURES OF A PROGRAMMATIC NATURE"", MEDICINAL PRODUCTS FOR PEOPLE, PACKAGED AND PREPACKAGED FOR RETAIL TRADE: - PULMOZIM(R), SOLUTION FOR INHALATION, 2.5 MG/2.5 ML PER 2.5 ML IN AN AMPOULE; 6 AMPOULES IN A CONTAINER; 1 CONTAINER IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 AMPOULE (2.5 ML) OF INHALATION SOLUTION CONTAINS: DORNASE ALFA1 -2.5 MG), 1 MG OF DORNASE ALFA CORRESPONDS TO 1000 UNITS) - ARTICLE: 10243308 SERIES: N0018B25-81UP - ARTICLE: 10243308 SERIES :N0020B28-38275UPMANUFACTURER: PRIMARY PACKAGING, SOURCE OF UNDEVELOPED PRODUCTS: WOODSTOCK STERILE SOLUTIONS INC., USA, SECONDARY PACKAGING, BATCH RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND, TESTING" | |
|
UNITED STATES | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
F Hoffmann La Roche Ag frequently asked questions
You can explore detailed shipment records of F Hoffmann La Roche Ag through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to F Hoffmann La Roche Ag. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to F Hoffmann La Roche Ag, helping you expand your sourcing network.
Eximpedia’s trade data highlights F Hoffmann La Roche Ag’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand F Hoffmann La Roche Ag’s trade activities.
Traders can collaborate with F Hoffmann La Roche Ag by contacting them through their official channels or visiting their headquarters for detailed trade discussions.